How do statins control neuroinflammation?

Inflammation Research

Volumn 52, Issue 10, 2003, Pages 399-403

  Adamson, P ^a   Greenwood, J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; SIMVASTATIN;

ALLERGIC ENCEPHALOMYELITIS; CELL INFILTRATION; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENCEPHALITIS; HUMAN; IMMUNOMODULATION; LEUKOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; LEUKOCYTES; MICE; NERVOUS SYSTEM DISEASES; NEUTROPHIL INFILTRATION;

EID: 0141956374     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-003-1201-9     Document Type: Review

References (17)

1. Stanislaus R, Pahan K, Singh AK, Singh I. Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin. Neurosci Lett 1999; 269: 71-4.
2. Stanislaus R, Singh AK, Singh I. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis. J Neurosci Res 2001; 66: 155-62.
3. Sadeghi MM, Collinge M, Pardi R, Bender JR. Simvastatin modulates cytokine-mediated endothelial cell adhesion molecule induction: Involvement of an inhibitory G-protein J Immunol 2000; 165: 2712-8.
4. Weitz-Schmidt G, Welzebbach K, Brinkmann V, Kamata T, Kallen J, Bruns C et al. Statins selectvely inhibit leukocyte function antigen-1 by binding to a novel integrin site. Nature Med 2000; 7: 687-92.
5. Youssef S, Stuve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002; 420; 78-84.
6. Greenwood J, Walters CE, Pryce G, Kanuga N, Beraud E, Baker D et al. (March 5) Statin attenuates experimental autoimmune encephalomyelitis through inhibition of brain endothelial Rhodependent leukocyte migration. FASEB J 2003; On line DOI 10.1096/fj.02-1014fje.
7. Pryce G, Male DK, Campbell I, Greenwood J. Factors controlling T-cell migration across rat cerebral endothelium in vitro. J Neuroimmunol 1997; 75: 84-94.
8. rh0 proteins. J Cell Biol 1992; 119: 617-29.
9. rho proteins. J Biol Chem 1992; 267: 20033-8.
10. Etienne S, Adamson P, Greenwood J, Strosberg AD, Cazaubon S, Couraud P-O. ICAM-1 signalling pathways associated with Rho activation in microvascular brain endothelial cells. J Immunol 1998; 161: 5755-61
11. Adamson P, Etienne S, Couraud P-O, Calder V, Greenwood J. T-lymphocyte migration through CNS endothelial cells involves signalling through endothelial ICAM-1 via a rho dependent pathway. J Immunol 1999; 162: 2964-73.
12. Walters CE, Pryce G, Baker D, Sebti SM, Greenwood J, Adamson P. Inhibition of rho GTPases with protein prenyl transferase inhibitors prevent leukocyte recruitment to the CNS and attenuate clinical signs of disease in an animal model of multiple sclerosis. J Immunol 2002; 168: 4087-94.
13. Wong B, Lumma WC, Smith AM, Sisko JT, Wright SD, Cai TQ. Statins suppress THP-1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranylgeranylation. J Leukoc Biol; 2001; 69: 959-962.
14. Neuhaus O, Strasser-Fuchs S, Fazekas F, Kieseier BC, Niederwieser G, Hartung HP et al. Statins as immunomodulators. Comparison with interferon-β1b in MS. Neurology 2002; 59: 990-7.
15. Aktas O, Waiczies S, Smorodchenko A, Dorr J, Seeger B, Prozorovski T et al. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J Exp Med 197: 725-33.
16. Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognised type of immunomodulator. Nature Med 2000; 6: 1399-402.
17. Volmer T, Durkalski V, Tyor W, Corboy J, Preiningerova J, Markovic-Plese S et al. An open label, single arm study of simvastatin as a therapy for multiple sclerosis (MS). Neurology 2003; 60 suppl 1: pA84